|

225Ac-ABD147 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Abdera Therapeutics Inc.1

Indications

  • Large Cell Neuroendocrine Carcinoma of the Lung1
  • Small Cell Lung Cancer (SCLC)1
  • Lung Cancer1
  • Cancer1

Newport Beach, California1 trial

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Hoag Memorial Hospital Presbyterian

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.